Rob A Vermond1, Harry J G M Crijns2, Jan G P Tijssen3, A Marco Alings4, Maarten P Van den Berg1, Hans L Hillege5, Dirk J Van Veldhuisen1, Isabelle C Van Gelder1, Michiel Rienstra6. 1. Department of Cardiology, University Medical Center Groningen, University of Groningen, PO Box 30.001, 9700 RB Groningen, The Netherlands. 2. Department of Cardiology, Maastricht University Medical Center, 6202 AZ Maastricht, The Netherlands. 3. Department of Cardiology, Academic Medical Center, University of Amsterdam, 1100 DD Amsterdam, The Netherlands. 4. Department of Cardiology, Amphia Hospital, 4800 RK Breda, The Netherlands. 5. Trial Coordination Center, Department of Epidemiology, University Medical Center Groningen, 9700 RB Groningen, The Netherlands. 6. Department of Cardiology, University Medical Center Groningen, University of Groningen, PO Box 30.001, 9700 RB Groningen, The Netherlands m.rienstra@umcg.nl.
Abstract
AIMS: Symptoms and symptom burden have a central place in diagnosis and management of atrial fibrillation (AF). The aim of the present study is to investigate whether severity of AF symptoms impacts prognosis in permanent AF. METHODS AND RESULTS: We studied the relation between AF symptom severity [quantified with the Toronto AF Severity Scale (AFSS)] and cardiovascular outcome in patients included in the RACE II study. The primary endpoint was a composite of cardiovascular morbidity and mortality. Secondary outcome was cardiovascular hospitalizations. Of 614 permanent AF patients in RACE II, AFSS questionnaires were available in 558 patients (91%). Mean age was 68 ± 8 years. One hundred and seventy-four patients (31%) reported a low score (score 0-3; lowest tertile), 190 patients (34%) reported a moderate score (score 4-9; middle tertile), and 194 (35%) reported a high score (score 10-35; highest tertile). Patients with the most severe symptoms were more often women, had higher N-terminal prohormone of brain natriuretic peptide concentrations, and had more previous heart failure hospitalizations. Median follow-up was 3.0 (interquartile range 2.3-3.0) years. The primary endpoint occurred most frequently in the highest tertile of the AFSS [16 (9%), 19 (10%), 36 (19%), respectively, P = 0.01], being mainly driven by heart failure hospitalizations [4 (2%), 1 (1%), 16 (8%), respectively, P < 0.001]. After multivariable adjustment, higher AFSS scores were associated with the primary endpoint [hazard ratio 1.38 (1.15-1.66), P = 0.001], as well as with cardiovascular hospitalizations [hazard ratio 1.33 (1.14-1.54), P < 0.001]. CONCLUSION: In permanent AF, after multivariable adjustment, symptom severity is associated with cardiovascular outcome. Published on behalf of the European Society of Cardiology. All rights reserved.
RCT Entities:
AIMS: Symptoms and symptom burden have a central place in diagnosis and management of atrial fibrillation (AF). The aim of the present study is to investigate whether severity of AF symptoms impacts prognosis in permanent AF. METHODS AND RESULTS: We studied the relation between AF symptom severity [quantified with the Toronto AF Severity Scale (AFSS)] and cardiovascular outcome in patients included in the RACE II study. The primary endpoint was a composite of cardiovascular morbidity and mortality. Secondary outcome was cardiovascular hospitalizations. Of 614 permanent AFpatients in RACE II, AFSS questionnaires were available in 558 patients (91%). Mean age was 68 ± 8 years. One hundred and seventy-four patients (31%) reported a low score (score 0-3; lowest tertile), 190 patients (34%) reported a moderate score (score 4-9; middle tertile), and 194 (35%) reported a high score (score 10-35; highest tertile). Patients with the most severe symptoms were more often women, had higher N-terminal prohormone of brain natriuretic peptide concentrations, and had more previous heart failure hospitalizations. Median follow-up was 3.0 (interquartile range 2.3-3.0) years. The primary endpoint occurred most frequently in the highest tertile of the AFSS [16 (9%), 19 (10%), 36 (19%), respectively, P = 0.01], being mainly driven by heart failure hospitalizations [4 (2%), 1 (1%), 16 (8%), respectively, P < 0.001]. After multivariable adjustment, higher AFSS scores were associated with the primary endpoint [hazard ratio 1.38 (1.15-1.66), P = 0.001], as well as with cardiovascular hospitalizations [hazard ratio 1.33 (1.14-1.54), P < 0.001]. CONCLUSION: In permanent AF, after multivariable adjustment, symptom severity is associated with cardiovascular outcome. Published on behalf of the European Society of Cardiology. All rights reserved.
Authors: Nassir F Marrouche; Oussama Wazni; Christopher McGann; Tom Greene; J Michael Dean; Lilas Dagher; Eugene Kholmovski; Moussa Mansour; Francis Marchlinski; David Wilber; Gerhard Hindricks; Christian Mahnkopf; Darryl Wells; Pierre Jais; Prashanthan Sanders; Johannes Brachmann; Jeroen J Bax; Leonie Morrison-de Boer; Thomas Deneke; Hugh Calkins; Christian Sohns; Nazem Akoum Journal: JAMA Date: 2022-06-21 Impact factor: 157.335
Authors: Kelly T Gleason; Cheryl R Dennison Himmelfarb; Daniel E Ford; Harold Lehmann; Laura Samuel; Hae Ra Han; Sandeep K Jain; Gerald V Naccarelli; Vikas Aggarwal; Saman Nazarian Journal: BMC Cardiovasc Disord Date: 2019-04-05 Impact factor: 2.298
Authors: Benita A Bamgbade; Saket R Sanghai; David D McManus; Darleen Lessard; Molly E Waring; Sarah Forrester; Isabelle Pierre-Louis; Jane S Saczynski Journal: Arch Gerontol Geriatr Date: 2020-05-28 Impact factor: 3.250
Authors: Astrid N L Hermans; Nikki A H A Pluymaekers; Theo A R Lankveld; Manouk J W van Mourik; Stef Zeemering; Trang Dinh; Dennis W den Uijl; Justin G L M Luermans; Kevin Vernooy; Harry J G M Crijns; Ulrich Schotten; Dominik Linz Journal: Int J Cardiol Heart Vasc Date: 2021-09-15
Authors: Monika Sadlonova; Jochen Senges; Jonas Nagel; Christopher Celano; Caroline Klasen-Max; Martin Borggrefe; Ibrahim Akin; Dierk Thomas; Christopher Jan Schwarzbach; Thomas Kleeman; Steffen Schneider; Matthias Hochadel; Tim Süselbeck; Harald Schwacke; Angelika Alonso; Markus Haass; Karl-Heinz Ladwig; Christoph Herrmann-Lingen Journal: J Clin Med Date: 2022-02-21 Impact factor: 4.241
Authors: Renate B Schnabel; Ladislav Pecen; Nargiz Rzayeva; Markus Lucerna; Yanish Purmah; Francisco M Ojeda; Raffaele De Caterina; Paulus Kirchhof Journal: J Am Heart Assoc Date: 2018-05-18 Impact factor: 5.501